David B. Thompson

5.3k citations

26 papers · 3.8k indexed · 3 hit papers · h-index 22

Molecular Biology top 2%
Genetics top 5%
Business and International Management top 0.5%
Biomedical Engineering
Organic Chemistry top 10%

Co-authors: David R. Liu John P. Guilinger John A. Zuris Zheng‐Yi Chen Yilai Shu Johnny H. Hu Morgan L. Maeder J. Keith Joung
Topics: CRISPR and Genetic Engineering (10 papers)RNA Interference and Gene Delivery (8 papers)Advanced biosensing and bioanalysis techniques (6 papers)
Cited by: Business and International Management Aging Molecular Biology
Journals: Nature Proceedings of the National Academy of Sciences Journal of the American Chemical Society
Partner nations: United States Canada China

In The Last Decade

David B. Thompson

26 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo

2014 1.2k citations John A. Zuris, David B. Thompson et al. Nature Biotechnology profile →
Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification

2014 651 citations John P. Guilinger, David B. Thompson et al. Nature Biotechnology profile →
Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents

2017 410 citations Xue Gao, Yong Tao et al. Nature profile →

Peers

Countries citing papers authored by David B. Thompson

Since Specialization

Citations

This map shows the geographic impact of David B. Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David B. Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David B. Thompson more than expected).

Fields of papers citing papers by David B. Thompson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David B. Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David B. Thompson. The network helps show where David B. Thompson may publish in the future.

Co-authorship network of co-authors of David B. Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of David B. Thompson. A scholar is included among the top collaborators of David B. Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David B. Thompson. David B. Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivo 2023 ·Nature Communications ·Yong Tao,Verónica Lamas,Wan Du,Wenliang Zhu,Yiran Li,Madelynn N. Whittaker,John A. Zuris,David B. Thompson,Arun Prabhu Rameshbabu,Yilai Shu,Xue Gao,Johnny H. Hu,(unknown),Weijia Kong,Xuezhong Liu,Hao Wu,Benjamin P. Kleinstiver,David R. Liu,Zheng‐Yi Chen	29
2	A SARS‐CoV‐2 Neutralization Assay Using Single Molecule Arrays 2021 ·Angewandte Chemie International Edition ·Tal Gilboa,Limor Cohen,Chi‐An Cheng,Roey Lazarovits,(unknown),Isaac Han,(unknown),(unknown),David B. Thompson,Richie E. Kohman,Ann E. Woolley,Elizabeth W. Karlson,David R. Walt	23
3	A SARS‐CoV‐2 Neutralization Assay Using Single Molecule Arrays 2021 ·Angewandte Chemie ·Tal Gilboa,Limor Cohen,Chi‐An Cheng,Roey Lazarovits,(unknown),Isaac Han,(unknown),(unknown),David B. Thompson,Richie E. Kohman,Ann E. Woolley,Elizabeth W. Karlson,David R. Walt	4
4	RNA-responsive elements for eukaryotic translational control 2021 ·Nature Biotechnology ·Evan M. Zhao,Angelo S. Mao,Helena de Puig,Kehan Zhang,Nathaniel D. Tippens,Xiao Tan,(unknown),Isaac Han,Peter Q. Nguyen,Emma J. Chory,(unknown),Pradeep Ramesh,David B. Thompson,Crystal Yuri Oh,(unknown),Max A. English,James J. Collins	58
5	The case for biotech on Mars 2020 ·Nature Biotechnology ·Shannon N. Nangle,(unknown),Lucas A. Hartsough,Natalie Jing,Christopher E. Mason,Massimo Merighi,(unknown),Pamela A. Silver,Mark Simon,Jacob L. Swett,David B. Thompson,Marika Ziesack	60
6	High-resolution specificity profiling and off-target prediction for site-specific DNA recombinases 2019 ·Nature Communications ·(unknown),Lena K. Afeyan,Vlado Dančík,Luke W. Koblan,David B. Thompson,Chas Leichner,Paul A. Clemons,David R. Liu	30
7	An anionic human protein mediates cationic liposome delivery of genome editing proteins into mammalian cells 2019 ·Nature Communications ·(unknown),Kevin T. Zhao,David B. Thompson,David R. Liu	29
8	Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agentsbreakdown → 2017 ·Nature ·Xue Gao,Yong Tao,Verónica Lamas,Mingqian Huang,Wei-Hsi Yeh,Bifeng Pan,Yujuan Hu,Johnny H. Hu,David B. Thompson,Yilai Shu,Yamin Li,Yin Wang,Shiming Yang,Qiaobing Xu,Daniel B. Polley,M. Charles Liberman,Weijia Kong,Jeffrey R. Holt,Zheng‐Yi Chen,David R. Liu	410
9	A programmable Cas9-serine recombinase fusion protein that operates on DNA sequences in mammalian cells 2016 ·Nucleic Acids Research ·(unknown),(unknown),David B. Thompson,Johnny H. Hu,David R. Liu	45
10	Small molecule–triggered Cas9 protein with improved genome-editing specificity 2015 ·Nature Chemical Biology ·(unknown),Vikram Pattanayak,David B. Thompson,John A. Zuris,David R. Liu	340
11	Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivobreakdown → 2014 ·Nature Biotechnology ·John A. Zuris,David B. Thompson,Yilai Shu,John P. Guilinger,(unknown),Johnny H. Hu,Morgan L. Maeder,J. Keith Joung,Zheng‐Yi Chen,David R. Liu	1160
12	Immunological basis in the pathogenesis and treatment of bladder cancer 2014 ·Expert Review of Clinical Immunology ·David B. Thompson,(unknown),Michael Feloney,Ralph J. Hauke,Devendra K. Agrawal	62
13	Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modificationbreakdown → 2014 ·Nature Biotechnology ·John P. Guilinger,David B. Thompson,David R. Liu	651
14	Engineering and Identifying Supercharged Proteins for Macromolecule Delivery into Mammalian Cells 2012 ·Methods in enzymology on CD-ROM/Methods in enzymology ·David B. Thompson,(unknown),David R. Liu	101
15	Cellular Uptake Mechanisms and Endosomal Trafficking of Supercharged Proteins 2012 ·Chemistry & Biology ·David B. Thompson,Roberto Villaseñor,Brent M. Dorr,Marino Zerial,David R. Liu	87
16	A Class of Human Proteins that Deliver Functional Proteins into Mammalian Cells In Vitro and In Vivo 2011 ·Chemistry & Biology ·(unknown),Kevin T. Beier,Tina Davis,Jen‐Chieh Tseng,Weida Li,David B. Thompson,Allen F. Shih,E May,Constance L. Cepko,Andrew L. Kung,Qiao Zhou,David R. Liu	90
17	Functional Polymer Laminates from Hyperthermal Hydrogen Induced Cross-Linking 2011 ·Langmuir ·David B. Thompson,(unknown),P. Crewdson,Matthew J. McEachran,(unknown),Gilles Arsenault,Woon‐Ming Lau,Elizabeth R. Gillies	16
18	Testing the functional tolerance of the Piers–Rubinsztajn reaction: a new strategy for functional silicones 2010 ·Chemical Communications ·John B. Grande,David B. Thompson,Ferdinand Gonzaga,Michael A. Brook	77
19	Selected Sulfonyl Compounds as Anticancer/Antimalarial Agents 2003 ·Australian Journal of Chemistry ·Richard Francis Langler,Robert L. Paddock,David B. Thompson,Ian Crandall,(unknown),Kevin C. Kain	26
20	Molecular genetics of a three-gene cluster in the Amy region of Drosophila. 1990 ·PubMed ·Winifred W. Doane,David B. Thompson,Rachel Norman,(unknown)	6

About David B. Thompson

David B. Thompson is a scholar working on Molecular Biology, Genetics and Sensory Systems, having authored 26 papers that have together received 3.8k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (10 papers), RNA Interference and Gene Delivery (8 papers) and Advanced biosensing and bioanalysis techniques (6 papers). The work is most often cited by research in Business and International Management (316 citations), Aging (158 citations) and Molecular Biology (3.2k citations). David B. Thompson has collaborated with scholars based in United States, Canada and China. Frequent co-authors include David R. Liu, John P. Guilinger, John A. Zuris, Zheng‐Yi Chen, Yilai Shu, Johnny H. Hu, Morgan L. Maeder, J. Keith Joung, Michael A. Brook and Vikram Pattanayak. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact